Elritercept: Clinical Trials

3 trials of Elritercept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3

Follow Elritercept: new trials by email Literature Review of Elritercept trials Research Report on Elritercept

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
TAK-226 - Myelodysplastic Syndromes
Phase 2RecruitingTakeda422026-04-222026-10-28
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Elritercept, Ruxolitinib - Myelofibrosis
Phase 2RecruitingTakeda1352021-12-162026-02-05
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Elritercept - Myelodysplastic Syndromes, Cytopenia
Phase 2RecruitingTakeda2102020-08-192026-10-19

Conditions studied

Myelodysplastic Syndromes (2)  ·  Anemia (1)  ·  Cytopenia (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocytopenia (1)

Sponsors

Takeda (3)

Countries

Australia (2)  ·  France (2)  ·  Spain (2)  ·  Brazil (1)  ·  Czechia (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2023 (2)